1.Recurrent Erlotinib-Induced Interstitial Lung Disease on Non-Small Cell Lung Cancer.
Sang Don PARK ; Areum KIM ; Jin Seok PARK ; Chun Ho SHIN ; Hae Sung NAM ; Lucia KIM ; Jae Wha CHO ; Jeong Sun RYU ; Seung Min KWAK
Tuberculosis and Respiratory Diseases 2009;67(5):445-448
Erlotinib (Tarceva(R)) has been considered to be a new, promising oral chemotherapy agent for local advanced or metastatic non-small cell lung cancer (NSCLC). Erlotinib is regarded as relatively safe, but interstitial lung disease (ILD) related to erlotinib has been reported on an infrequent basis in Asia. We report an histologically confirmed case of recurrent erlotinib-induced ILD. Although, the patient was highly responsive to the first erlotinib treatment, the therapy was discontinued due to erlotinib-induced ILD. After intravenous high dose methylpredinisolone treatment, ILD was improved rapidly by radiologic studies, but the particular lung cancer re-emerged. We restarted the patient erlotinib on low-dose oral methylpredinisolone, resulting in a recurrence of erlotinib-induced ILD. Our case suggests that re-administration of erlotinib should be performed on a limited basis in patients that have developed ILD on previous use, even if a therapeutic effect can be estimated.
Asia
;
Carcinoma, Non-Small-Cell Lung
;
Humans
;
Lung Diseases, Interstitial
;
Lung Neoplasms
;
Quinazolines
;
Recurrence
;
Erlotinib Hydrochloride
2.Recurrent Erlotinib-Induced Interstitial Lung Disease on Non-Small Cell Lung Cancer.
Sang Don PARK ; Areum KIM ; Jin Seok PARK ; Chun Ho SHIN ; Hae Sung NAM ; Lucia KIM ; Jae Wha CHO ; Jeong Sun RYU ; Seung Min KWAK
Tuberculosis and Respiratory Diseases 2009;67(5):445-448
Erlotinib (Tarceva(R)) has been considered to be a new, promising oral chemotherapy agent for local advanced or metastatic non-small cell lung cancer (NSCLC). Erlotinib is regarded as relatively safe, but interstitial lung disease (ILD) related to erlotinib has been reported on an infrequent basis in Asia. We report an histologically confirmed case of recurrent erlotinib-induced ILD. Although, the patient was highly responsive to the first erlotinib treatment, the therapy was discontinued due to erlotinib-induced ILD. After intravenous high dose methylpredinisolone treatment, ILD was improved rapidly by radiologic studies, but the particular lung cancer re-emerged. We restarted the patient erlotinib on low-dose oral methylpredinisolone, resulting in a recurrence of erlotinib-induced ILD. Our case suggests that re-administration of erlotinib should be performed on a limited basis in patients that have developed ILD on previous use, even if a therapeutic effect can be estimated.
Asia
;
Carcinoma, Non-Small-Cell Lung
;
Humans
;
Lung Diseases, Interstitial
;
Lung Neoplasms
;
Quinazolines
;
Recurrence
;
Erlotinib Hydrochloride
3.Cytokine-like Activity of Liver Type Fatty Acid Binding Protein (L-FABP) Inducing Inflammatory Cytokine Interleukin-6.
Hyunwoo KIM ; Gaae GIL ; Siyoung LEE ; Areum KWAK ; Seunghyun JO ; Ensom KIM ; Tam T NGUYEN ; Sinae KIM ; Hyunjhung JHUN ; Somi KIM ; Miyeon KIM ; Youngmin LEE ; Soohyun KIM
Immune Network 2016;16(5):296-304
It has been reported that fatty acid binding proteins (FABPs) do not act only as intracellular mediators of lipid responses but also have extracellular functions. This study aimed to investigate whether extracellular liver type (L)-FABP has a biological activity and to determined serum L-FABP levels in patients with end-stage renal disease (ESRD). We isolated L-FABP complementary deoxyribonucleic acid (cDNA) from the Huh7 human hepatocarcinoma cell line and expressed the recombinant L-FABP protein in Escherichia coli. A549 lung carcinoma and THP-1 monocytic cells were stimulated with the human recombinant L-FABP. Human whole blood cells were also treated with the human recombinant L-FABP or interleukin (IL)-1α. IL-6 levels were measured in cell culture supernatants using IL-6 enzyme-linked immunosorbent assay (ELISA). Human recombinant L-FABP induced IL-6 in a dose-dependent manner in A549, THP-1 cells, and whole blood cells. The blood samples of healthy volunteers and patients with ESRD were taken after an overnight fast. The serum levels of L-FABP in healthy volunteers and ESRD patients were quantified with L-FABP ELISA. The values of L-FABP in patients with ESRD were significantly lower than those in the control group. Our results demonstrated the biological activity of L-FABP in human cells suggesting L-FABP can be a mediator of inflammation.
Blood Cells
;
Carrier Proteins*
;
Cell Culture Techniques
;
Cell Line
;
DNA
;
Enzyme-Linked Immunosorbent Assay
;
Escherichia coli
;
Fatty Acid-Binding Proteins
;
Healthy Volunteers
;
Humans
;
Inflammation
;
Interleukin-6*
;
Interleukins
;
Kidney Failure, Chronic
;
Liver*
;
Lung
4.IL-32-induced Inflammatory Cytokines Are Selectively Suppressed by α1-antitrypsin in Mouse Bone Marrow Cells.
Siyoung LEE ; Dong Ki CHOI ; Areum KWAK ; Sinae KIM ; Tam Thanh NGUYEN ; Gaae GIL ; Eunhye KIM ; Kwang Ha YOO ; In Ae KIM ; Youngmin LEE ; Hyunjhung JHUN ; Edward D CHAN ; Xiyuan BAI ; Hyunwoo KIM ; Yong Sung KIM ; Soohyun KIM
Immune Network 2017;17(2):116-120
The induction of interleukin (IL)-32 in bone marrow (BM) inflammation is crucial in graft versus host disease (GvHD) that is a common side effect of allogeneic BM transplantation. Clinical trials on α-1 antitrypsin (AAT) in patients with GvHD are based on the preliminary human and mouse studies on AAT reducing the severity of GvHD. Proteinase 3 (PR3) is an IL-32-binding protein that was isolated from human urine. IL-32 primarily induces inflammatory cytokines in myeloid cells, probably due to PR3 expression on the membrane of the myeloid lineage cells. The inhibitory activity of AAT on serine proteinases may explain the anti-inflammatory effect of AAT on GvHD. However, the anti-inflammatory activity of AAT on BM cells remains unclear. Mouse BM cells were treated with IL-32γ and different inflammatory stimuli to investigate the anti-inflammatory activity of AAT. Recombinant AAT-Fc fusion protein inhibited IL-32γ-induced IL-6 expression in BM cells, but failed to suppress that induced by other stimuli. In addition, the binding of IL-32γ to PR3 was abrogated by AAT-Fc. The data suggest that the specific anti-inflammatory effect of AAT in mouse BM cells is due to the blocking of IL-32 binding to membrane PR3.
Animals
;
Bone Marrow Cells*
;
Bone Marrow*
;
Cytokines*
;
Graft vs Host Disease
;
Humans
;
Inflammation
;
Interleukin-6
;
Interleukins
;
Membranes
;
Mice*
;
Myeloblastin
;
Myeloid Cells
;
Serine Proteases
5.Species Specific Antiviral Activity of Porcine Interferon-α8 (IFNα8).
Eunhye KIM ; Hyunjhung JHUN ; Joohee KIM ; Unjoo PARK ; Seunghyun JO ; Areum KWAK ; Sinae KIM ; Tam T. NGUYEN ; Yongsun KANG ; Insoo CHOI ; Joongbok LEE ; Heijun KIM ; Younghyun KIM ; Siyoung LEE ; Soohyun KIM
Immune Network 2017;17(6):424-436
Interferons (IFNs) have been known as antiviral genes and they are classified by type 1, type 2, and type 3 IFN. The type 1 IFN consists of IFNα, IFNβ, IFNτ, and IFNω whereas the type 2 IFN consists of only IFNγ, which is a key cytokine driving T helper cell type 1 immunity. IFNλ belongs to the type 3 IFN, which is also known as IL-28 and IL-29 possessing antiviral activities. Type 1 IFN is produced by viral infection whereas type 2 IFN is induced by mitogenic or antigenic T-cell stimuli. The IFNτ of bovine was first discovered in an ungulate ruminant recognition hormone. IFNτ belongs to the type 1 IFN with the common feature of type 1 IFN such as antiviral activity. IFNs have been mostly studied for basic research and clinical usages therefore there was no effort to investigate IFNs in industrial animals. Here we cloned porcine IFNα8 from peripheral blood mononuclear cells of Korean domestic pig (Sus scrofa domestica). The newly cloned IFNα8 amino acid sequence from Korean domestic pig shares 98.4% identity with the known porcine IFNα8 in databank. The recombinant porcine IFNα8 showed potent antiviral activity and protected bovine Madin-Darby bovine kidney epithelial (MDBK) cells from the cytopathic effect of vesicular stomatitis virus, but it failed to protect human Wistar Institute Susan Hayflick (WISH) cells and canine Madin-Darby canine kidney epithelial-like (MDCK) cells. The present study demonstrates species specific antiviral activity of porcine IFNα8.
Amino Acid Sequence
;
Animals
;
Clone Cells
;
Humans
;
Interferons
;
Kidney
;
Ruminants
;
Sus scrofa
;
T-Lymphocytes
;
T-Lymphocytes, Helper-Inducer
;
Vesicular Stomatitis